Dr Rebecca Clark

Research Fellow

United Kingdom

Email
Rebecca

I have a PhD in Infectious Disease Epidemiology from LSHTM, an MSc in Epidemiology from the University of Alberta and a BSc (Honours) in Biology and Mathematics from McMaster University. I am currently a Research Fellow in the Department of Infectious Disease Epidemiology & Dynamics at LSHTM. My research is focussed on using mathematical modelling to evaluate the health and economic impacts of interventions to reduce the burden of tuberculosis, primarily of new vaccines.

Affiliations

Department of Infectious Disease Epidemiology and Dynamics

Faculty of Epidemiology and Population Health

Research

Research Area

Epidemiology

Mathematical modelling

Vaccines

Disease and Health Conditions

Tuberculosis

Country

India

Selected Publications

Estimating the potential health and economic impacts of new tuberculosis vaccines under varying delivery strategies in Delhi and Gujarat, India: a modelling study

CLARK, RA; Portnoy, A; Weerasuriya, CK; SUMNER, T; Bakker, R; Harris, RC; Rade, K; Mattoo, SK; Tumu, D; Menzies, NA; WHITE, RG;

2024

The Lancet regional health - Southeast Asia

Bridging the gap: evaluating high TB burden country data needs to support the potential introduction of TB vaccines for adolescents and adults: a workshop report

CLARK, RA; Young, C; Palmer, S; Auma, E; Malhotra, S; Limaye, R; Giersing, B; Schrager, L; Voss, G; Tiemersma, E; Frick, M; Edoka, I; Dagnew, AF; Nkhoma, T; Pelzer, PT; WHITE, RG;

2024

Frontiers in Tuberculosis

Estimating the Potential Public Health Value of BCG Revaccination.

CLARK, RA; SUMNER, T; Weerasuriya, CK; Bakker, R; Scriba, TJ; WHITE, RG;

2024

The Journal of infectious diseases

New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01E and BCG-revaccination.

CLARK, RA; Weerasuriya, CK; Portnoy, A; Mukandavire, C; Quaife, M; Bakker, R; Scarponi, D; Harris, RC; Rade, K; Mattoo, SK; Tumu, D; Menzies, NA; WHITE, RG;

2023

BMC medicine

The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study.

CLARK, RA; Mukandavire, C; Portnoy, A; WEERASURIYA, CK; Deol, A; SCARPONI, D; Iskauskas, A; Bakker, R; Quaife, M; Malhotra, S; Gebreselassie, N; Zignol, M; Hutubessy, RC W; Giersing, B; JIT, M; Harris, RC; Menzies, NA; WHITE, RG;

2023

The Lancet. Global health

The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study.

Portnoy, A; CLARK, RA; Quaife, M; WEERASURIYA, CK; Mukandavire, C; Bakker, R; Deol, AK; Malhotra, S; Gebreselassie, N; Zignol, M; Sim, SY; Hutubessy, RC W; Baena, IG; Nishikiori, N; JIT, M; WHITE, RG; Menzies, NA;

2023

PLOS Medicine

New tuberculosis vaccines: advances in clinical development and modelling.

WEERASURIYA, CK; CLARK, RA; WHITE, RG; Harris, RC;

2020

Journal of internal medicine

lshtm-tbmg/tbmod-pub-undernutrition

Clark, R;

2024

Zenodo

The potential impact of new TB vaccines on the burden of TB in people living with HIV in South Africa.

SUMNER, T; CLARK, RA; PRYS-JONES, TO; Bakker, R; Churchyard, G; WHITE, RG;